Page last updated: 2024-11-04

sanguinarine and Cardiac Hypertrophy

sanguinarine has been researched along with Cardiac Hypertrophy in 1 studies

benzophenanthridine alkaloid : A specific group of isoquinoline alkaloids that occur only in higher plants and are constituents mainly of the Papaveraceae family.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research Excerpts

ExcerptRelevanceReference
"Sanguinarine protected against the cardiac hypertrophy, fibrosis and dysfunction induced by AB, as assessed by the heart weight/body weight, lung weight/body weight and heart weight/tibia length ratios, echocardiographic and hemodynamic parameters, histological analysis, and the gene expression levels of hypertrophic and fibrotic markers."1.40Sanguinarine protects against pressure overload‑induced cardiac remodeling via inhibition of nuclear factor-κB activation. ( Cheng, Z; Deng, W; Fang, Y; He, M; Li, W; Lin, Y; Liu, Y; Sun, D; Tang, Q; Zhang, J; Zhang, R; Zhang, Y; Zhou, H, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, W1
Fang, Y1
Liu, Y1
Zhou, H1
Cheng, Z1
Zhang, Y1
Sun, D1
He, M1
Lin, Y1
Zhang, R1
Zhang, J1
Li, W1
Tang, Q1

Other Studies

1 other study available for sanguinarine and Cardiac Hypertrophy

ArticleYear
Sanguinarine protects against pressure overload‑induced cardiac remodeling via inhibition of nuclear factor-κB activation.
    Molecular medicine reports, 2014, Volume: 10, Issue:1

    Topics: Animals; Benzophenanthridines; Cardiomegaly; Echocardiography; Hemodynamics; Isoquinolines; Male; Mi

2014